Topics: Passive antibody therapy CVVH This program will discuss antibody transmission via homologous plasma transfusions and Continuous VenoVenous Hemofiltration for inflammatory mediator mitigation.
Joseph has been a practicing clinical perfusionist for 40 years. Joseph is the CEO of Houston Extracorporeal Technologies and is the program director of The New Orleans Conference